Tech Company Financing Transactions

Chase Pharmaceuticals Funding Round

On 5/13/2014, Chase Pharmaceuticals received $21 million in Series B funding from New Rhein Healthcare Investors, Cipla Ventures and Edmond de Rothschild Investment Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1825 K St. Northwest 520
Washington, DC 20006
USA

Phone

(202) 223-7002

Website

www.chasepharmaceuticals.com

Email Address

Not Recorded

Overview

Chase Pharmaceuticals is engaged in the clinical development of medically improved treatments for central nervous system (CNS) diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Siebert

        

Chief Medical Officer

Kathleen Clarence-Smith

        

Chief Scientific Officer

Thomas Chase

        

Browse more venture capital transactions:

Prev: 5/13/2014: Shareablee venture capital transaction
Next: 5/13/2014: Boxed venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to record tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary